Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Parkinson’s disease

Study identifies biomarkers predicting cognitive decline in early Parkinson’s disease

Significant findings offer scope for the development of clinical trials and personalised treatments for Parkinson’s disease.

Cognitive impairment is a characteristic feature of Parkinson’s disease (PD), with dementia affecting up to 80% of patients long term, according to epidemiological studies.

To explore which factors predict cognitive decline, US and international researchers assessed and followed up 423 patients newly diagnosed with PD for up to three years.

The researchers found that, by year three, cognitive impairment was diagnosed in 15–38% of the participants and cognitive impairment had increased in frequency by 50–200% depending on the criteria applied.

In multivariate analysis, the researchers found that biomarker changes including dopamine deficiency, decreased global brain volume and co-morbid Alzheimer’s disease plaque pathology all independently predicted cognitive impairment. They also identified two predictive genetic markers, COMT val/val and BDNF val/val.

Reporting in PLOS ONE[1] (online, 17 May 2017), the team says the findings could help the design of future clinical trials for disease-modifying therapies and could also be a step towards personalised medicine.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202935

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • MRI brain scan

Jobs you might like

See more jobs

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.